You've built a groundbreaking innovation. You've identified a clear market niche. You're ready to transform clinical trials. But when you finally secure that meeting with a top-tier pharmaceutical company, the conversation shifts quickly from your "cool tech" to a barrage of rigorous, technical, and regulatory questions.

In my 20+ years of building and scaling clinical technology, I've seen brilliant startups stall because they weren't prepared for the "Pharma Inquisition." Pharma doesn't just buy technology; they buy reduced risk and faster timelines. If you can't answer their core questions with evidence, you're a liability, not a solution.

Based on the ClinTech Market Readiness Framework, here are the 10 questions you must be prepared to answer, along with guidance on how to build your "Artifact Pack" to prove you're pharma-ready.

1. "Is your system validated for GxP environments?"

Pharma operates under strict Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) guidelines. They need to know your software development lifecycle (SDLC) follows a formal validation process.

How to Prepare

Have your SOP Index and Validation Package (IQ/OQ/PQ) ready. Be prepared to show how you handle change control and system updates without breaking compliance.

2. "How do you comply with 21 CFR Part 11 and Annex 11?"

If you are capturing electronic records or signatures, this is non-negotiable. Regulators require secure logins, time-stamped audit trails, and linked electronic signatures.

How to Prepare

Provide an Audit Trail Sample and a Traceability Matrix. Show them exactly how your system ensures data integrity from the moment of entry to final export.

3. "What is your data privacy and cross-border transfer strategy?"

With GDPR in Europe, HIPAA in the US, and strict laws like China's PIPL, pharma needs to know exactly where data sits and how it moves.

How to Prepare

Create a Data Flow Diagram showing storage, transfer, and subprocessors. Have a standard Data Processing Agreement (DPA) ready for their legal team to review.

4. "Can you demonstrate SOC 2 Type II or ISO 27001 certification?"

Internal security "best practices" aren't enough for enterprise pharma. They require third-party validation of your security controls.

How to Prepare

If you don't have these certifications yet, show your roadmap to achieving them. At a minimum, provide a Penetration Test Summary from a reputable third party.

5. "How does your tool integrate with our existing ecosystem (EDC, eTMF, CTMS)?"

Pharma hates data silos. If your tool doesn't "talk" to their existing platforms, you're adding manual work and increasing the risk of errors.

How to Prepare

Provide API Documentation and, ideally, access to a Sandbox Environment. Show evidence of successful integrations or support for industry standards like CDISC or FHIR.

6. "What is the specific ROI — and do you have pilot data to prove it?"

"Faster trials" is a generic claim. Pharma wants to see quantifiable impact: "Reduction in site workload by 20%" or "15% improvement in patient retention."

How to Prepare

Build an ROI Calculator based on industry benchmarks. If you have pilot data, present it in an Anonymized Pilot Dataset or a KOL Memo from a respected investigator.

7. "What is your plan for site and patient burden?"

If your tech is hard for a busy clinical site to use, they won't use it. If it's confusing for a patient, they'll drop out of the study.

How to Prepare

Show your System Usability Scale (SUS) scores or Net Promoter Scores (NPS) from early users. Provide a sample Training Curriculum to show how you simplify onboarding.

8. "How do you handle AE/SAE reporting and signal detection?"

Patient safety is the highest priority. If your tool captures health data, you must have a clear workflow for identifying and reporting Adverse Events.

How to Prepare

Document your AE/SAE Handling Workflow. Show how your system alerts medical monitors to potential safety signals in real-time.

9. "What happens if your system goes down during a global trial?"

A system outage in a Phase 3 trial can cost millions and jeopardize patient safety. Pharma needs to see your "safety net."

How to Prepare

Provide your Business Continuity and Disaster Recovery Plan. Define your Service Level Agreements (SLAs) for support and uptime.

10. "Are you prepared for a formal Quality Audit?"

Before you sign a Master Service Agreement (MSA), pharma's Quality Assurance (QA) team will likely audit your office, your code, and your processes.

How to Prepare

Conduct a Mock Audit using a consultant who knows pharma expectations. Build a "Database of Responses" for the lengthy vendor qualification questionnaires you will inevitably receive.

The Bottom Line

Pharma doesn't buy technology; they buy trust. By preparing these artifacts and answers in advance, you move from being a "risky startup" to a "trusted partner."

Ready to see where your gaps are? Take our Pharma Readiness Self-Assessment to get your score and a personalized roadmap.

Karen Maduschke

Karen Maduschke

Karen is the founder of ClinTech Strategy Partners. She has spent 20+ years navigating the path from startup innovation to global pharma leadership. Schedule a call to discuss your market entry strategy.

← Back to Insights